Search

Author/Creator Breinholt, Vibeke Miller

1. Design and Preclinical Development of TransCon PTH, an Investigational Sustained‐Release PTH Replacement Therapy for Hypoparathyroidism. (9th October 2019)

Authors:
Holten‐Andersen, Lars; Pihl, Susanne; Rasmussen, Caroline E; Zettler, Joachim; Maitro, Guillaume; Baron, Julia; Heinig, Stefan; Hoffmann, Eric; Wegge, Thomas; Krusch, Mathias; Faltinger, Frank; Killian, Steffen; Sprogoe, Kennett; Karpf, David B; Breinholt, Vibeke Miller; Cleemann, Felix
Journal:
Journal of bone and mineral research
Issue:
Volume 34:Number 11(2019)
Page Start:
2075
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamics results of a long‐acting C‐type natriuretic peptide prodrug, TransCon CNP. Issue 11 (1st June 2022)

Authors:
Breinholt, Vibeke Miller; Mygind, Per Holse; Christoffersen, Eva Dam; Zhang, Ying; Ota, Sho; Will Charlton, R.; Viuff, Dorthe
Journal:
British journal of clinical pharmacology
Issue:
Volume 88:Issue 11(2022)
Page Start:
4763
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. TransCon IL-2 β/γ: a novel long-acting prodrug with sustained release of an IL-2Rβ/γ-selective IL-2 variant with improved pharmacokinetics and potent activation of cytotoxic immune cells for the treatment of cancer. Issue 7 (11th July 2022)

Authors:
Rosen, David B; Kvarnhammar, Anne Månsson; Laufer, Burkhardt; Knappe, Thomas; Karlsson, Jens Jakob; Hong, Enping; Lee, Yu-Chi; Thakar, Dhruv; Zúñiga, Luis Alejandro; Bang, Kathy; Sabharwal, Simran Singh; Uppal, Karan; Olling, Janne Damm; Kjaergaard, Kristian; Kurpiers, Thomas; Schnabel, Meike; Re...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 7(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗